Is Cytosorbents Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Cytosorbents Corp (CTSO) is currently classified as HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Cytosorbents Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Cytosorbents Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Cytosorbents Corp?

Muslim investors may consider investing in Cytosorbents Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Cytosorbents Corp classified as HALAL?

Musaffa determines the Shariah status of Cytosorbents Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Cytosorbents Corp updated?

The Shariah compliance status of Cytosorbents Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Cytosorbents Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Cytosorbents Corp?

You can check the latest Shariah compliance status of Cytosorbents Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

CTSO Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: April 01, 2026

Report Source: 2025 Annual Report

Cytosorbents Corp. Stock Analysis CTSO

United States Health Care Nano Cap Report: 2025 Annual

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. The company is headquartered in Princeton, New Jersey and currently employs 129 full-time employees. The company went IPO on 2005-06-17. The Company’s blood purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its lead product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses that can lead to massive inflammation, organ failure and patient death. Its products also include ECOS-300CY, VetResQ, DrugSorb-ATR, and PuriFi. DrugSorb-ATR is an investigational device that uses equivalent polymer technology to CytoSorb to address a large unmet need for blood thinner reversal in cardiothoracic surgery. ECOS-300CY is used to reduce cytokines and other inflammatory mediators when used in an ex vivo organ perfusion system.

Key Statistics of Cytosorbents Corp (CTSO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.49$0.55

Today's Open

$0.53

Volume

190.01K

P/E Ratio (TTM)

52 Week Range

$0.49$1.39

Market Cap

38.00M

Avg. Volume

70.64K

Dividend Yield

Financial Metrics & Statements of Cytosorbents Corp (CTSO)

FAQ's for Cytosorbents Corp (CTSO)

According to Musaffa’s Shariah screening methodology, Cytosorbents Corp (CTSO) is currently classified as HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.